Metagenomi Begins Genetic Treatment IPO Rollout (Pending:MGX)


Lab tech in protective gloves putting a slide with a scientific sample under a microscope

fotostorm/E+ via Getty Images

A Quick Take On Metagenomi

Metagenomi, Inc. (MGX) has filed to raise $100 million in an IPO of its common stock, according to an SEC S-1/A registration statement.

The firm is developing a genetic editing

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *